Verified Nov 2026
Other
·

Durham, North Carolina
·
Since 2005
Aerie Pharmaceuticals develops ophthalmic therapies for glaucoma and dry eye disease. Founded in 2005 and headquartered in Durham, North Carolina, the company operated as a clinical-stage pharmaceutical firm with 100–200 employees before its acquisition by Swiss eye-care firm Alcon in 2025. Its marketed products include Rhopressa and Rocklatan, once-daily eye drop therapies designed to lower intraocular pressure.
Aerie Pharmaceuticals at a glance
Employees
100-200
Founded
2005
Headquarters
Durham, North Carolina
Industries
Automotive
Electric Vehicles
Medical
Overview
Aerie Pharmaceuticals develops ophthalmic therapies for glaucoma and dry eye disease. Founded in 2005 and headquartered in Durham, North Carolina, the company operated as a clinical-stage pharmaceutical firm with 100–200 employees before its acquisition by Swiss eye-care firm Alcon in 2025. Its marketed products include Rhopressa and Rocklatan, once-daily eye drop therapies designed to lower intraocular pressure.
At a glance
Attribute | Detail |
|---|---|
Founded | 2005 |
Headquarters | Durham, North Carolina |
Employees | 100-200 |
What Aerie Pharmaceuticals makes
The company develops once-daily eye drop therapies with novel mechanisms for lowering intraocular pressure, and its product portfolio includes treatments for glaucoma and dry eye disease.
Latest developments
2026-01-29 — TRYPTYR by Aerie Pharmaceuticals expected to drive market size of Dry Eye Disease | ABNewswire (abnewswire.com)
2025-12-16 — Alcon Expands Foothold in Eye Sector with $770 Million Aerie Pharmaceuticals Purchase (chemrobotics.com)
2025-09-17 — Alcon Completes Acquisition of Aerie Pharmaceuticals - Eyewire+ (eyewire.news)
2025-07-04 — Aerie Pharmaceuticals (wikipedia.org)
2025-03-13 — Aerie Pharmaceuticals, Inc - InvestSnips (investsnips.com)
Facilities
Aerie Pharmaceuticals is headquartered in Durham, North Carolina. Public sources also reference these locations:
Durham, North Carolina — sec.gov
Company details
Following its acquisition by Alcon, Aerie's therapies are now distributed through Alcon's network, expanding their reach within the global ophthalmic pharmaceutical market. Aerie Pharmaceuticals was founded in 2005, has an estimated 100-200 employees, and is headquartered in Durham, North Carolina.
Frequently asked questions
What does Aerie Pharmaceuticals do?
Aerie Pharmaceuticals develops ophthalmic therapies for glaucoma and dry eye disease. Founded in 2005 and headquartered in Durham, North Carolina, the company operated as a clinical-stage pharmaceutical firm with 100–200 employees before its acquisition by Swiss eye-care firm Alcon in 2025. Its marketed products include Rhopressa and Rocklatan, once-daily eye drop therapies designed to lower intraocular pressure.
Where is Aerie Pharmaceuticals headquartered?
Aerie Pharmaceuticals is headquartered in Durham, North Carolina (4301 Emperor Blvd, Durham, North Carolina, 27703-7615).
When was Aerie Pharmaceuticals founded?
Aerie Pharmaceuticals was founded in 2005.
How big is Aerie Pharmaceuticals?
Aerie Pharmaceuticals has an estimated 100-200 employees.
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.
